255 related articles for article (PubMed ID: 33998872)
1. Use and Perceptions of Cannabidiol Products in Canada and in the United States.
Goodman S; Wadsworth E; Schauer G; Hammond D
Cannabis Cannabinoid Res; 2022 Jun; 7(3):355-364. PubMed ID: 33998872
[No Abstract] [Full Text] [Related]
2. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Hammond D; Goodman S
Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
[No Abstract] [Full Text] [Related]
3. Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study.
Hammond D; Goodman S; Wadsworth E; Freeman TP; Kilmer B; Schauer G; Pacula RL; Hall W
Int J Drug Policy; 2022 Jul; 105():103716. PubMed ID: 35613480
[TBL] [Abstract][Full Text] [Related]
4. Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers.
Zenone MA; Snyder J; Crooks V
BMC Public Health; 2021 Jul; 21(1):1285. PubMed ID: 34210299
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.
Fedorova EV; Wong CF; Ataiants J; Iverson E; Conn BM; Lankenau SE
Drug Alcohol Depend; 2021 Apr; 221():108648. PubMed ID: 33676073
[TBL] [Abstract][Full Text] [Related]
6. Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops.
Leas EC; Moy N; McMenamin SB; Shi Y; Benmarhnia T; Stone MD; Trinidad DR; White M
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206501
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
[TBL] [Abstract][Full Text] [Related]
8. Young adults' knowledge, perceptions and use of cannabidiol products: a mixed-methods study.
Wysota CN; Le D; Clausen ME; Ciceron AC; Fuss C; Bennett B; Romm KF; Duan Z; Berg CJ
Health Educ Res; 2022 Nov; 37(6):379-392. PubMed ID: 36217613
[TBL] [Abstract][Full Text] [Related]
9. Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults.
Dunbar MS; Seelam R; Tucker JS; Firth CL; Pedersen ER; Klein DJ; Rodriguez A; D'Amico EJ
Addict Behav; 2022 Mar; 126():107185. PubMed ID: 34839070
[TBL] [Abstract][Full Text] [Related]
10. Self-reported THC content and associations with perceptions of feeling high among cannabis consumers.
Lineham J; Wadsworth E; Hammond D
Drug Alcohol Rev; 2023 Jul; 42(5):1142-1152. PubMed ID: 37062952
[TBL] [Abstract][Full Text] [Related]
11. Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.
Boehnke KF; Gagnier JJ; Matallana L; Williams DA
J Pain; 2021 Nov; 22(11):1418-1428. PubMed ID: 33992787
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol Knowledge, Perceptions, and Use Among Young Adults in 6 U.S. Metropolitan Areas.
Wysota CN; Henriksen L; Romm KF; Duan Z; Wang Y; Huang J; Berg CJ
Cannabis Cannabinoid Res; 2023 Dec; 8(6):1140-1149. PubMed ID: 35878060
[No Abstract] [Full Text] [Related]
13. Trends and Socio-Demographic Differences of Cannabis Vaping in the USA and Canada.
Lim CCW; Chan GCK; Wadsworth E; Stjepanović D; Chiu V; Chung JYC; Sun T; Connor J; Leung J; Gartner C; Hall W; Hammond D
Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361272
[TBL] [Abstract][Full Text] [Related]
14. Access to cannabidiol without a prescription: A cross-country comparison and analysis.
McGregor IS; Cairns EA; Abelev S; Cohen R; Henderson M; Couch D; Arnold JC; Gauld N
Int J Drug Policy; 2020 Nov; 85():102935. PubMed ID: 32919298
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
Miller OS; Elder EJ; Jones KJ; Gidal BE
Epilepsy Behav; 2022 Feb; 127():108514. PubMed ID: 34998268
[TBL] [Abstract][Full Text] [Related]
16. Clinicians' Guide to Cannabidiol and Hemp Oils.
VanDolah HJ; Bauer BA; Mauck KF
Mayo Clin Proc; 2019 Sep; 94(9):1840-1851. PubMed ID: 31447137
[TBL] [Abstract][Full Text] [Related]
17. CBD (Cannabidiol) Product Attitudes, Knowledge, and Use Among Young Adults.
Wheeler M; Merten JW; Gordon BT; Hamadi H
Subst Use Misuse; 2020; 55(7):1138-1145. PubMed ID: 32093530
[No Abstract] [Full Text] [Related]
18. Assessment of hemp oil-based cannabidiol use in a community-based pharmacy setting.
Gicewicz E; Gatewood SS; Kaefer TN; Nadpara P; Goode JR
J Am Pharm Assoc (2003); 2021; 61(4S):S49-S56. PubMed ID: 33745856
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol use and perceptions in France: a national survey.
Casanova C; Ramier C; Fortin D; Carrieri P; Mancini J; Barré T
BMC Public Health; 2022 Aug; 22(1):1628. PubMed ID: 36038869
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with ever using cannabidiol in a cohort of younger pregnant people.
De Genna NM; Kennon-McGill S; Goldschmidt L; Richardson GA; Chang JC
Neurotoxicol Teratol; 2023; 96():107162. PubMed ID: 36717004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
